Veracyte
VCYT
#3754
Rank
NZ$6.47 B
Marketcap
NZ$80.60
Share price
3.74%
Change (1 day)
32.54%
Change (1 year)

Earnings for Veracyte (VCYT)

Earnings in 2026 (TTM): NZ$0.20 Billion

According to Veracyte's latest financial reports the company's current earnings are NZ$0.56 Billion. In 2025 the company made an earning of NZ$0.12 Billion, an increase over its 2024 earnings that were of NZ$42.76 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Veracyte from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.20 B65.85%
2025 NZ$0.12 B184.15%
2024 NZ$42.76 M-131.34%
2023 -NZ$0.14 Billion111.42%
2022 -NZ$64.56 Million-55.5%
2021 -NZ$0.15 Billion134.74%
2020 -NZ$61.8 Million190.89%
2019 -NZ$21.25 Million-43.33%
2018 -NZ$37.49 Million-23.78%
2017 -NZ$49.18 Million-3.51%
2016 -NZ$50.97 Million-14.17%
2015 -NZ$59.39 Million15.17%
2014 -NZ$51.56 Million14.15%
2013 -NZ$45.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Exact Sciences
EXAS
-NZ$0.33 Billion-257.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-NZ$0.69 Billion-432.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-NZ$62.31 Million-130.14%๐Ÿ‡บ๐Ÿ‡ธ USA